Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Euronext Paris  >  PCAS    PCA   FR0000053514

PCAS (PCA)

Delayed Quote. Delayed  - 09/28 05:01:57 pm
10.31 EUR   -0.96%
09/14 PCAS : ex-dividend day for interim dividend
09/07 PCAS : 1st half 2016 earnings report continued organic growth
09/02PCAS : half-yearly earnings release
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 
Latest news on PCAS
09/14 PCAS : ex-dividend day for interim dividend
09/07 PCAS : 1st half 2016 earnings report continued organic growth
09/02PCAS : half-yearly earnings release
07/19 PCAS : Net sales for the 1st half of 2016
07/19 PCAS : SUSTAINED GROWTH IN NET SALES FOR THE 1st HALF OF 2016
07/13 PCAS : signs a global distribution agreement with MilliporeSigma
07/13 PCAS : sign a global distribution agreement with MilliporeSigma
07/12 PCAS : Signs a global distribution agreement with MilliporeSigma, enabling a bet..
06/28 PCAS : Inauguration of a new workshop at the couterne site
06/28 PCAS : Inauguration of a new workshop at the couterne site
06/22 PCAS : confirms its PME SME eligibility
06/07 PCAS : Collaboration Syngenta
06/07 PCAS : Syngenta Collaboration
06/06 PCAS : A new collaboration for enzyme optimization between syngenta and protéus ..
06/06 PCAS : A new collaboration for enzyme optimization between syngenta and protéus ..
05/24 PCAS : Allocation of free shares
04/28 PCAS : Corporate name change
04/27 PCAS : Corporate name change
04/27 PCAS : ex-dividend day for final dividend
04/25 PCAS : enters into a manufacturing agreement with ABIVAX
04/25 PCAS : Enters into a manufacturing agreement with abivax
04/20 PCAS : Q1 2016 Net sales
04/20 PCAS - 2016 Q1 SALES : Sharp growth in net sales again
04/14 PCAS : US patent granted for PCAS new Cinacalcet production process
03/31 PCAS : 2015 Annual Report
03/17 PCAS : Shareholder's Letter
03/01 PCAS : Presentation of 2015 performance
02/18 PCAS : 2015 Earnings
02/18 PCAS : 2015 earnings up sharply
02/18 PCAS : 2015 Net Sales
02/15 PCAS : 8% bonds dated - 31/12/2016 buy back
02/15 PCAS : 8% bonds dated- 31/12/2016 buy back
02/02 PCAS : 2015 sales - strong growth
2015 PCAS : Sales as of 30 september 2015, +4.8 % growth
2015 PCAS : ADEME acquires a stake in ENERSENS
2015 PCAS : Ademe acquires a stake in enersens as part of the 'investments for the fu..
2015 PCAS : ex-dividend day for interim dividend
2015 PCAS : 2015 HYR - Very good operational performance Pharma focus yields strong g..
2015 PCAS : Sustained growth in net sales for the first half of 2015
2015 PCAS : Participation de PCAS au Forum d’affaires France-Chine à Paris le 1..
2015 PCAS : takes part in the China-France Business Forum held in Paris on July 1st, ..
2015 PCAS : reinforces its management team and hires several new staff members within..
2015 PCAS : reinforces its management team and hires several new staff members within..
2015 PCAS : Strengthens its foothold in pharmaceuticals in north america
2015 PCAS : 2015 - 2016 financial calendar
2015 PCAS : Obtains the "innovative business" label awarded by bpifrance
2015 PCAS : ex-dividend day for annual dividend
2015 PCAS : Sales as of march 31, 2015
2015 PCAS : Confirmation of PEA-PME plan eligibility for 2015/2016
2015 PCAS : MOONLINER® by ENERSENS: ultra-insulating natural-based wall cladding
2015 PCAS : 2014 Results - Strong Financials and growth prospects lead to return to d..
2015 PCAS : Expansia has been nominated by UCB Pharma "Vendor of the year 2014"
2014 PCAS : ENERSENS Homeskin project
2014 PCAS : leads the European Union Horizon 2020 Homeskin
2014 PCAS : includes a new Scientific Board in its governance
2014 PCAS : Protéus : At the heart of the Vadébio project
2014 PCAS : joins the new EnterNext© PEA-PME 150 index
2014 PCAS : through its subsidiary Proteus, is contributing to the conversion of wood..
2014 PCAS : joins the new EnterNext© PEA-PME 150 index
2014 PCAS : Quarterly Financial Information as of 30 September 2014
2014 PCAS : and its subsidiary Protéus at the heart of the Green Epoxy project
2014 PCAS : Successful closing of a EuroPP and a syndicated loan for a total of €45m
2014 PCAS : 2014 half-year results
2014 PCAS : 2014 first-half sales
2014 PCAS : PCAS: QUARTERLY FINANCIAL INFORMATION As of March 31, 2014
2014 PCAS : Glycopyrrolate
2014 PCAS : CHBD in China & CPHI in Japan
2014 PCAS : CHBD in China & CPHI in Japan
2014 PCAS : Gycopyrrolate
2014 PCAS : PEA-PME plan eligibility
2014 PCAS : Collaboration with Actavis for a new drug substance in late clinical phas..
2014 PCAS : Resignation and appointment of directors
2014 PCAS : Resignation and appointment of directors
2014 PCAS : 2013 results
2014 PCAS : 2013 Net Sales
1  2Next
Advertisement
Financials (€)
Sales 2016 196 M
EBIT 2016 19,0 M
Net income 2016 11,0 M
Debt 2016 31,0 M
Yield 2016 1,15%
P/E ratio 2016 12,70
P/E ratio 2017 10,84
EV / Sales 2016 0,96x
EV / Sales 2017 0,89x
Capitalization 158 M
More Financials
Chart PCAS
Duration : Period :
PCAS Technical Analysis Chart | PCA | FR0000053514 | 4-Traders
Full-screen chart
Technical analysis trends PCAS
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Average target price 11,0 €
Spread / Average Target 5,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Vincent Touraille CEO & Financial Communications Contact
Christian Moretti Chairman
Pierre Schreiner Deputy Chief Executive Officer-Operations
Eric Moissenot Deputy CEO-Finance & Administration
Gérard Guillamot Director-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
PCAS30.61%178
JOHNSON & JOHNSON16.06%322 232
ROCHE HOLDING LTD.-12.41%215 081
NOVARTIS AG-10.14%211 231
PFIZER INC.4.80%204 049
MERCK & CO., INC.18.46%171 858
More Results